Los Angeles, CA85 Active Studies

Ankylosing Spondylitis Clinical Trials in Los Angeles, CA

Find 85 actively recruiting ankylosing spondylitis clinical trials in Los Angeles, CA. Connect with local research sites and explore new treatment options.

85
Active Trials
60
Sponsors
198,664
Enrolling

Recruiting Ankylosing Spondylitis Studies in Los Angeles

About Ankylosing Spondylitis Clinical Trials in Los Angeles

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 85 ankylosing spondylitis clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 198,664 participants. Research is being sponsored by Hoffmann-La Roche, Pfizer, Arbor Research Collaborative for Health and 57 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Los Angeles — FAQ

Are there ankylosing spondylitis clinical trials in Los Angeles?

Yes, there are 85 ankylosing spondylitis clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 85 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated October 17, 2026 from ClinicalTrials.gov